|Related Categories||Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, CI-CY, Cell Biology, Cell Signaling and Neuroscience,|
|color||white to off-white|
|solubility||DMSO: >20 mg/mL|
CP-101537 is a MMP inhibitor, candidate drug for myocardial infarction therapy, and antibacterial.
Sold for research purposes under agreement from Pfizer Inc.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Need larger quantities for your development, manufacturing or research applications?